适应性临床试验设计,以快速开发疫苗:发展中国家疫苗制造商的观点
Manish Mahajan1, Laura B Martin2, Kumar Gaurav3
1Zydus Lifesciences, India.
Vaccine
|November 2, 2025
概括
适应性临床试验设计通过允许数据驱动的修改来加速疫苗开发. 这优化了效率和监管监督,使全球疫苗获得更快,更具成本效益.
科学领域:
- 临床试验 临床试验
- 疫苗学 疫苗学 疫苗学
- 监管科学 监管科学
背景情况:
- 适应性临床试验设计为疫苗开发提供了显著的优势.
- 这些设计允许基于临时数据进行计划的修改,提高效率和成功率.
研究的目的:
- 探索适应性临床试验设计在疫苗开发中的好处和挑战.
- 强调对国家监管机构 (NRA) 和制药行业的影响,特别是在低收入和中等收入国家 (LMICs).
主要方法:
- 在临床试验中对适应性设计原则的审查.
- 对监管机构和行业的好处的分析.
- 识别挑战和实施缓解策略.
主要成果:
- 适应性设计提高了试验效率,缩短了时间表,并增加了成功的可能性,同时保持完整性.
- 国家监管机构获得更早的安全性/有效性见解,使得对疫苗的监督和更快的疫苗接入成为可能.
- 产业从优化资源配置和敏捷开发计划中受益.
结论:
- 采用适应性设计需要转向动态,基于数据的策略和早期监管调整.
- 解决统计,运营和后勤复杂性至关重要,特别是在LMICs.
- 成功实施加速了疫苗的可用性,支持全球卫生和行业创新.
相关概念视频
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
171
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
171
Preclinical Development: Overview
5.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.8K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
218
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
218
Study Designs in Epidemiology
870
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
870


